Details of the Drug Reposition

General Information of This Drug (ID: DMQD6B9)

Drug Name
Anti-HER2 CAR-T   DMQD6B9
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
6 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glioma DIS5RPEH 2A00.0 Phase 1/2 [1]
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1/2 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 1/2 [1]
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
Lung cancer DISCM4YA 2C25.0 Phase 1/2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1/2 [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)

References

1 ClinicalTrials.gov (NCT02713984) A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer